William E. Delaney IV - 29 Apr 2024 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role
Chief Scientific Officer
Signature
/s/ John O. Gunderson, as Attorney-in-Fact
Issuer symbol
ASMB
Transactions as of
29 Apr 2024
Transactions value $
$0
Form type
4
Filing time
01 May 2024, 16:05:08 UTC
Previous filing
02 Apr 2024
Next filing
01 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASMB Common Stock Award $0 +3,333 +26% $0 16,109 29 Apr 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved.
F2 Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9.